Years of Life Lost and Productivity TB1 SY2 Costs Due to Premature Cancer-Related Mortality in Morocco
Author(s)
Shira Yaari, PhD1, El Mehdi Raki, M Sc2, Ihsane Eljoudani, M Sc2, Anne Meiwald, M Sc3, Aimee Fox, PhD4, Chamath Perera, M Sc4, Peter Toth, M Sc4, Bernadette Poellinger, PhD5.
1MSD Merck Sharp & Dohme, Tel Aviv, Israel, 2MSD Merck Sharp & Dohme, Casablanca, Morocco, 3Adelphi Values, Bollington, United Kingdom, 4Adelphi Values PROVE, Bollington, United Kingdom, 5Director Oncology Outcomes Research, MSD, München, Germany.
1MSD Merck Sharp & Dohme, Tel Aviv, Israel, 2MSD Merck Sharp & Dohme, Casablanca, Morocco, 3Adelphi Values, Bollington, United Kingdom, 4Adelphi Values PROVE, Bollington, United Kingdom, 5Director Oncology Outcomes Research, MSD, München, Germany.
OBJECTIVES: Multiple cancer types have high mortality and afflict individuals at a relatively young age, leading to substantial productivity losses and premature death. This study aims to provide a perspective on cancer mortality burden and productive life lost due to cancer types in Morrocco.
METHODS: The human capital approach was used to estimate both years of life lost (YLL) and the present value of future loss of productivity (PVFLP). Age- and sex-specific mortality data were sourced from the Institute for Health Metrics and Evaluation (IHME). Years of productive life lost (YPLL) measures the number of working years lost prior to the standard retirement age of 60 years, thus capturing the impact of premature mortality on economic productivity.
RESULTS: In 2022, 19,744 patients died of cancer in Morocco. Lung, colorectum, breast, cervical, ovary and endometrial cancer are amongst the cancers with the highest mortality with an estimated number of 4,934, 2,782, 1,809, 1,092, 551 and 114 deaths in 2022, respectively. We estimated that all cancer deaths resulted in overall 250,663 YLL, with lung accounting for 42,470, colorectum for 31,692, breast for 38,056, cervical for 22,865, ovary for 9,244 and endometrial cancer for 1,531 and YLL in 2022. Annual PVFLP was estimated to be $248,982,938 for all cancer types, with lung accounting for $32,830,576, colorectum for $28,976,897, breast for $41,832,883 cervical for $23,934,688, ovary for $7,814,125 and endometrial cancer for $1,004,463, respectively.
CONCLUSIONS: YLL and PVFLP due to premature cancer mortality in Morocco were substantial, with lung, colorectum, breast, cervical, ovary and endometrial cancer having a major impact. Continuing prioritization investment in cancer care including awareness, prevention, early detection and treatment is imperative and should take priority to reduce societal burden for Morocco.
METHODS: The human capital approach was used to estimate both years of life lost (YLL) and the present value of future loss of productivity (PVFLP). Age- and sex-specific mortality data were sourced from the Institute for Health Metrics and Evaluation (IHME). Years of productive life lost (YPLL) measures the number of working years lost prior to the standard retirement age of 60 years, thus capturing the impact of premature mortality on economic productivity.
RESULTS: In 2022, 19,744 patients died of cancer in Morocco. Lung, colorectum, breast, cervical, ovary and endometrial cancer are amongst the cancers with the highest mortality with an estimated number of 4,934, 2,782, 1,809, 1,092, 551 and 114 deaths in 2022, respectively. We estimated that all cancer deaths resulted in overall 250,663 YLL, with lung accounting for 42,470, colorectum for 31,692, breast for 38,056, cervical for 22,865, ovary for 9,244 and endometrial cancer for 1,531 and YLL in 2022. Annual PVFLP was estimated to be $248,982,938 for all cancer types, with lung accounting for $32,830,576, colorectum for $28,976,897, breast for $41,832,883 cervical for $23,934,688, ovary for $7,814,125 and endometrial cancer for $1,004,463, respectively.
CONCLUSIONS: YLL and PVFLP due to premature cancer mortality in Morocco were substantial, with lung, colorectum, breast, cervical, ovary and endometrial cancer having a major impact. Continuing prioritization investment in cancer care including awareness, prevention, early detection and treatment is imperative and should take priority to reduce societal burden for Morocco.
Conference/Value in Health Info
2025-11, ISPOR Europe 2025, Glasgow, Scotland
Value in Health, Volume 28, Issue S2
Code
EPH280
Topic
Economic Evaluation, Epidemiology & Public Health, Health Policy & Regulatory
Disease
Oncology